Table 2: Comparison to other studies.

Present study Hacke et al. [13]Smith et al. [15]Smith et al. [7]Penumbra Pivotal Stroke Trial [6]Nelles et al. [23]MR CLEAN [20]

(100%)3140614116412565500
Target vesselICA, MCAICA, MCAICA, MCA, VA, BAICA, MCA, VA, BAICA, MCA, VA, BAICA, MCAICA, MCA, ACA
i.v. thrombolysis with rtPA31 (100%)406 (100%)No48 (29%)n/a#n/a445 (89%)
Mechanical recanalization31 (100%)no141 (100%)164 (100%)125 (100%)65 (100%)##195 (39%)
Hematoma6 (19.4%)120 (29.5%)50 (35.5%)16 (9.8%)35 (28%)3 (5%)##35 (7%)

i.v. and also i.a. thrombolysis.
#Only the percentage of i.v. rtPA in case of bleeding, not the overall i.v. rtPA rate.
##Only TICI 2b and TICI 3, where they administered only 50% of the usual dose.